Concordance between HPV DNA detection and HPV seroprevalence for HPV16 and HPV18 among eligible MSM
| Seroprevalence | HPV DNA detection | |||
| HPV16-negative/HPV18-negative | HPV16-positive/HPV18-negative | HPV16-negative/HPV18-positive | HPV16-positive/HPV18-positive | |
| Seronegative for both HPV16 and HPV18 | 279 (57.6) | 25 (5.2) | 13 (2.7) | 1 (0.2) |
| HPV16 seropositive and HPV18 seronegative | 58 (12.0) | 21 (4.3) | 4 (0.8) | 0 (0.0) |
| HPV16 seronegative and HPV18 seropositive | 24 (5.0) | 0 (0.0) | 3 (0.6) | 1 (0.2) |
| Seropositive for both HPV16 and HPV18 | 36 (7.4) | 11 (2.3) | 3 (0.6) | 5 (1.0) |
| Total | 397 | 57 | 23 | 7 |
Number in brackets represents percentage of the total eligible samples (N=484).
Grey shaded cells are the numbers with fully concordant serology and HPV DNA detection results.
HPV, human papillomavirus; MSM, men who have sex with men.